Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Azacitidine (AZA) Combined with Idarubicin in Higher Risk MDS - Results of a Phase I/II Study By the Groupe Francophone Des Myelodysplasies (GFM)

Marie Sebert, MD, Aspasia Stamatoullas, MD, Thorsten Braun, MD PhD, Jacques Delaunay, MD, Benoît de Renzis, Ramzi Jeddi, MD, Balkis Meddeb, Mathilde Hunault Berger, Benedicte Samey, Fatiha Chermat, Sylvie Chevret, Cendrine Chaffaut, Pierre Fenaux, MD PhD, Lionel Ades, MD PhD

Blood (2015) 126 (23): 2884.

https://doi.org/10.1182/blood.V126.23.2884.2884

Published: 2015

Journal Articles

Azacitidine (AZA) Combined with Idarubicin in Untreated Patients with High Risk MDS – Results of a Phase I/II Study of the Groupe Francophone Des Myelodysplasies

Lionel Ades, MD, PhD, Benoit de Renzis, Ramzi Jeddi, MD, Jacques Delaunay, MD, Thorsten Braun, Mathilde Hunault Berger, MD, PhD, Aspasia Stamatoullas, Laurence Sanhes, MD, Benedicte Samey, Fatiha Chermat, Baklis Meddeb, Pierre Fenaux, MD, PhD

Blood (2012) 120 (21): 1720.

https://doi.org/10.1182/blood.V120.21.1720.1720

Published: 2012

Journal Articles

Adult ALL Patients Treated with Pediatric Inspired Trials Have Inacceptable Early Death but Better Relapse Free Survival Compared to Adult Trials: A Tunisian Single Center Experience

Hend Ben Neji, Yosr Ben Abdennebi, Lamia Aissaoui, Ramzi Jeddi, Mohamed Zarrouk, Ramzi Ben amor, Karima Kacem, Raihane Ben Lakhal, Zaher Belhadj Ali, Hela Ben Abid, Balkis Meddeb

Blood (2012) 120 (21): 4297.

https://doi.org/10.1182/blood.V120.21.4297.4297

Published: 2012

Journal Articles

Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results?

Ramzi Jeddi, Hèla Ghédira, Hèla Stambouli, Ramzi Ben amor, Karima Kacem, MD, Yosr Ben Abdennebi, Mohamed Zarrouk, Hend Ben Neji, Raihane ben Lakhal, Lamia Aissaoui, Samia Menif, Emna Gouider, Hèla Ben Abid, Zaher Ben Hadjali, Pierre Fenaux, MD, PhD, Balkis Meddeb, MD

Blood (2011) 118 (21): 4271.

https://doi.org/10.1182/blood.V118.21.4271.4271

Published: 2011

Journal Articles

High Body Mass Index (BMI) as a Predictor of Differentiation Syndrome (DS) In Acute Promyelocytic Leukemia (APL).

Ramzi Jeddi, Béchir Achour, Agnès Guerci-Bresler, Héla Ghédira, Hervé Dombret, Françoise Huguet, Patrice Chevallier, Norbert Vey, Stephane de Botton, Dominique Bordessoule, Beatrice U. Muller, Virginie Eclache, Claude Gardin, Balkis Meddeb, Lionel Adès, Pierre Fenaux, MD, PhD

Blood (2010) 116 (21): 1078.

https://doi.org/10.1182/blood.V116.21.1078.1078

Published: 2010

Journal Articles

Predictive Factors of Severe Sepsis and Septic Shock in Patients with Hematological Malignancies and Pseudomonas Infections.

Ramzi Jeddi, Hèla Ghédira, Ramzi ben Amor, Lamia Aissaoui, Karima Kacem, Walid Bouterâa, Yosr ben Abdennebi, Raihane ben Lakhal, Amel Turki, Hèla ben Abid, Zaher Belhadjali, Balkis Meddeb

Blood (2009) 114 (22): 4552.

https://doi.org/10.1182/blood.V114.22.4552.4552

Published: 2009

Journal Articles

Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial

Blood (2008) 111 (4): 1805–1810.

https://doi.org/10.1182/blood-2007-07-101212

Published: 2008

Includes: Supplemental data

Journal Articles

Timing of Second Autologous Transplantations in Multiple Myeloma: Results of a Multicenter Sequential Randomized Clinical Trial.

Abderrahman Abdelkefi, MD, Saloua Ladeb, MD, Tarek Ben Othman, MD, Lamia Torjman, MD, Amel Lakhal, MD, Neila Ben Romdhane, Halima El Omri, Moez Elloumi, Hatem Bellaj, Ramzi Jeddi, Lamia Aissaoui, Fahmi Msadek, Ali Saad, Mohamed Hsairi, Kamel Boukef, Ahlem Amouri, Hechmi Louzir, Koussay Dellagi, Abdeladhim Ben Abdeladhim

Blood (2006) 108 (11): 59.

https://doi.org/10.1182/blood.V108.11.59.59

Published: 2006

NARROW

Azacitidine (AZA) Combined with Idarubicin in Higher Risk MDS - Results of a Phase I/II Study By the Groupe Francophone Des Myelodysplasies (GFM)

Azacitidine (AZA) Combined with Idarubicin in Untreated Patients with High Risk MDS – Results of a Phase I/II Study of the Groupe Francophone Des Myelodysplasies

Adult ALL Patients Treated with Pediatric Inspired Trials Have Inacceptable Early Death but Better Relapse Free Survival Compared to Adult Trials: A Tunisian Single Center Experience

Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results?

High Body Mass Index (BMI) as a Predictor of Differentiation Syndrome (DS) In Acute Promyelocytic Leukemia (APL).

Predictive Factors of Severe Sepsis and Septic Shock in Patients with Hematological Malignancies and Pseudomonas Infections.

Single autologous stem-cell transplantation followed by maintenance therapy with thalidomide is superior to double autologous transplantation in multiple myeloma: results of a multicenter randomized clinical trial

Timing of Second Autologous Transplantations in Multiple Myeloma: Results of a Multicenter Sequential Randomized Clinical Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only